Загрузка...
Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
BACKGROUND AND AIMS: Thrombocytopenia is a common hematological abnormality observed in patients infected with hepatitis C virus (HCV). The use of eltrombopag has been approved for HCV-associated thrombocytopenia. This is the first study aiming to determine the predictive factors of response to eltr...
Сохранить в:
| Опубликовано в: : | Ther Clin Risk Manag |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6375108/ https://ncbi.nlm.nih.gov/pubmed/30804674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S186106 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|